J
John P. Boehmer
Researcher at Penn State Milton S. Hershey Medical Center
Publications - 162
Citations - 16317
John P. Boehmer is an academic researcher from Penn State Milton S. Hershey Medical Center. The author has contributed to research in topics: Heart failure & Cardiac resynchronization therapy. The author has an hindex of 42, co-authored 145 publications receiving 15087 citations. Previous affiliations of John P. Boehmer include University of Alabama at Birmingham & Rush University Medical Center.
Papers
More filters
Journal Article
The incremental risk of female sex in heart transplantation
M. R. Johnson,David C. Naftel,Robert E. Hobbs,Jon A. Kobashigawa,D. Pitts,T. B. Levine,D. Tolman,G. Bhat,J.K. Kirklin,Robert C. Bourge,David C. McGiffin,T. Wiess,A. Crosswy,B. Austin,Lesley Early,P. Holmes,M. Veazey,P. Sims,K. Hubbard,J. Brush,Marc R. Pritzker,K. D. Lake,M. O'Kane,Scott A. Chapman,F. Hoffman,N. Seimers,Charles R. Jorgensen,Wes R. Pedersen,Lyle D. Joyce,Frazier Eales,Robert W. Emery,T. Von Reuden,P. Bruhn,M. King,Kit V. Arom,K. J. Heilman,D. Pacheco,Charity G. Moore,S. Levin,P. Blair,Hector O. Ventura,Frank W. Smart,D. D. Stapleton,Van Meter C.H.,Mandeep R. Mehra,Debi Dumas-Hicks,J. B. Young,J. A. Farmer,B. Cocanougher,S. Lanthier,G. H. Mudge,John A. Jarcho,P. Johnson,E. Loh,Gustavo Rincon,Corinne Bott-Silverman,Patrick M. McCarthy,Robert W. Stewart,L. Platt,R. E. Michler,E. M. Burke,R. Gomez,F. Hoy,D. Geis,J. Munns,D. Best,Barry S. Clemson,P. McRae,C. Stables,S. Faulkner,M. L. Stenstrom,S. Brozena,J. M. Fitzpatrick,A. K. Gash,D. Chojnowski,J. Kozak,P. Stutman,C. Twomey,D. Stinson,A. B. Levine,B. Narins,John P. Boehmer,P. Frazier,P. Coe,J.A. O'Donnell,A. Darroca,L. Hiles,R. L. Caldwell,R. K. Darragh,T. Flaspholer,Maria Rosa Costanzo,W. Kao,E. Winkel +92 more
TL;DR: In this article, the effect of previous pregnancy on the outcome (incidence of rejection and death) of females after heart transplantation was investigated and it was shown that it is previous pregnancy, and not sex per se, that is associated with an increased frequency of rejection in females after transplantation.
Journal ArticleDOI
Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: Results of the oral enoximone in intravenous inotrope-dependent subjects trial
Arthur M. Feldman,Ron M. Oren,William T. Abraham,John P. Boehmer,Peter E. Carson,Eric J. Eichhorn,Edward M. Gilbert,Andrew Kao,Carl V. Leier,Brian D. Lowes,Michael A. Mathier,Frank McGrew,Marco Metra,Lawrence S. Zisman,Simon F. Shakar,Steven K. Krueger,Alastair D. Robertson,Bill G. White,Michael J. Gerber,Gwyn E. Wold,Michael R. Bristow +20 more
TL;DR: The EMOTE data suggest that low-dose oral enoximone can be used to wean a modest percentage of subjects from i.v. inotropic support for up to 90 days after initiation of therapy.
Journal ArticleDOI
Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β1-Adrenergic Receptors
Yuji Nagatomo,Dennis M. McNamara,Jeffrey D. Alexis,Leslie T. Cooper,G. William Dec,Daniel F. Pauly,Richard Sheppard,Randall C. Starling,W.H. Wilson Tang,Karen Janosko,Charles F. McTiernan,Barry London,Karen Hanley-Yanez,John Gorcsan,Hidekazu Tanaka,Mathew Suffoletto,Cynthia Oblak,Annette McNallan,Lu Anne Koenig,Paul J. Mather,Natalie Pierson,Sharon Rubin,Yanique Bell,Alicia Ervin,John P. Boehmer,Patricia Frey,Jeffrey D. Alexis,Janice Schrack,Pam LaDuke,Guillermo Torre-Amione,Jeannie Arredondo,Pamela C. Smith,Stephanie Fuoco,Ilan S. Wittstein,Elayne Breton,Vinay Thohan,Deborah J. Wesley,Diane Cocca-Spofford,David W. Markham,Lynn Fernandez,Colleen H. Debes,Mark J. Zucker,Laura Adams,Peter Liu,Judith Renton,Jagat Narula,Byron Allen,Elizabeth Westberg +47 more
TL;DR: In patients with high New York Heart Association functional class (III or IV) at baseline, the IgG3 group had a lower incidence of the composite endpoint of all-cause death, cardiac transplantation, and hospitalization due to heart failure, whereas the non-IgG3 groups had the highest incidence ofthe composite endpoint.
Journal ArticleDOI
Endotheliopathy: a continuum of hemolytic uremic syndrome due to mitomycin therapy.
TL;DR: A continuum of HUS presenting as a multisystem, progressive disorder has not been previously reported and it is proposed that a diffuse ongoing endothelial cell dysfunction (ie, endotheliopathy) is the putative mechanism for this patient's clinical course.
Journal ArticleDOI
Evaluating the older adult experience of a web-based, tablet-delivered heart failure self-care program using gerontechnology principles
Harleah G. Buck,Anthony T. Pinter,Erika Shehan Poole,John P. Boehmer,Andrew Foy,Sara Black,Tom Lloyd +6 more
TL;DR: The qualitative analysis of participant post‐intervention interviews from the tablet‐delivered Penn State Heart Assistant intervention suggested improved goal attainment and satisfaction with life for the older adults with use of the tablet.